Nils Wilking, MD, PhD / Associate professor Karolinska Institutet, Stockholm, Sweden
Associate professor Nils Wilking (NW) MD PhD has been active in clinical oncology for 40 years after graduating from the Karolinska Institutet in Stockholm, Sweden in 1977. NW has worked for many years in the field of surgical oncology, but has since the late 1980s mainly worked within medical oncology with a focus on breast and GI cancer.
NW headed the Breast and GI Cancer Unit at the Karolinska hospital during 1992-1998. During this period, he also set up and headed the clinical trial unit at the Department of Oncology. In 1998, NW joined Eli Lilly as a senior research physician. In 2001, he moved to BMS where he held a European position in their oncology team. Since 2003, he has worked in a research context linked to the Karolinska Institutet.
2010-17, NW served as Senior Strategic Advisor for the Southern Health Care Region in Sweden. 2012-2016, NW was also head of the Oncology department at Skåne University hospital in Lund (the largest cancer clinic in Sweden).
NWs main focus has been on research in relation to health service delivery. NW has published a number of reports in the cancer area: http://www.comparatorreports.se/
Most recent report in 2019: https://ihe.se/publicering/comparator-report-on-cancer-in-europe-2019-2/
Oncology at the forefront of measuring outcomes – The status of cancer care in EU